Microbiota-derived pantothenic acid rapidly restores colonic mucus barrier after antibiotic-induced dysbiosis

Intestinal mucus serves as the body's primary defense against the gut microbiota. When antibiotics disrupt the microbial balance, known as dysbiosis, this crucial barrier can be compromised. However, the exact processes that enable a swift recovery of the mucus barrier remain largely unknown. A recent study has identified a new player in this dynamic: pantothenic acid, also known as vitamin B5.

By analyzing the gut microbiota of mice following antibiotic treatment, researchers found a correlation between an increase in Muribaculaceae bacteria, higher levels of pantothenic acid in the feces, and thicker colonic mucus. Out of the various Muribaculaceae species tested, only Sangeribacter muris was capable of producing pantothenic acid.

Exposing the compromised mucus layer to an external source of pantothenic acid led to a rapid restoration of its thickness. Importantly, this beneficial effect occurred without any observable changes in gene transcription. The restoration of the mucus barrier was also shown to be non-autonomous, suggesting that it functions through a non-epithelial mechanism.

These findings reveal a previously unidentified pathway where microbiota-derived pantothenic acid plays a crucial role in maintaining the integrity of the colonic mucus barrier. This discovery not only sheds new light on the complex interactions between the microbiome, host metabolism, and barrier integrity but also opens up new avenues for potential therapeutic interventions.